Table 3.

SARS-CoV-2 variants features and CD147 antibody inhibition rate

Virus name	Country of origin	Mutations (AA)	Meplazumab inhibition rate (60 μg/ml)	Source
SARS-CoV-2	China		68.7%	National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention
Alpha	United Kingdom	HV69-70 Del, Y145 Del, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H	75.7%
Beta	South Africa	D80A, D215G, LAL242–244 Del, E484K, K417N, N501Y, D614G, A701V	52.1%
Gamma	Brazil	L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F	52.1%
Delta	India	T19R, T95I, G142D, L452R, T478K, D614G, P681R, D950N, R158del	62.3%